首页> 外国专利> POLYEPITOPE PROTEIN, NUCLEOTIDE SEQUENCE CODING POLYEPITOPE PROTEIN, PLASMID WITH SEQUENCE CODING POLYEPITOPE PROTEIN, AND PREPARATION OF POLYEPITOPE PROTEIN FOR INDUCTION OF IMMUNE RESPONSE ON MURRAIN VIRUS

POLYEPITOPE PROTEIN, NUCLEOTIDE SEQUENCE CODING POLYEPITOPE PROTEIN, PLASMID WITH SEQUENCE CODING POLYEPITOPE PROTEIN, AND PREPARATION OF POLYEPITOPE PROTEIN FOR INDUCTION OF IMMUNE RESPONSE ON MURRAIN VIRUS

机译:多聚体蛋白,编码多聚体蛋白的核苷酸序列,带有序列编码多聚体蛋白的质粒,以及用于诱导对鼠病毒的免疫反应的多聚体蛋白的制备

摘要

FIELD: medicine.;SUBSTANCE: invention refers to a polyepitope vaccine protein applicable for immunisation against murrain virus, nucleic acid coding this protein, recombinant plasmid pA7248-AMV-H-PE for production of said protein in plants and to a vaccine preparation for prevention and protection against infection caused by murrain virus. The polyepitope vaccine protein has the amino acid sequence SEQ ID NO: 1 which contains the amino acid sequence of B-cell epitope of VP4 protein from 21-th to 40-th amino acid starting with N-terminal, the amino acid sequence of B-cell epitope of VP1 protein from 135-th to 160-th amino acid starting with N-terminal, the amino acid sequence of B-cell epitope of VP1 protein from 200-th to 213-th amino acid starting with N-terminal, the amino acid sequence of T-cell epitope of 2C protein from 68-th to 76-th amino acid starting with N-terminal, the amino acid sequence of T-cell epitope of 3D protein from 1-st to 115-th amino acid starting from N-terminal, and the amino acid sequence of T-cell epitope of 3D protein from 421-st to 460-th amino acid of murrain virus serotype O/ Taiwan/99. Nucleic acid coding such protein has the nucleotide sequence SEQ ID NO: 2. Recombinant plasmid pA7248-AMV-H-PE has a physical map presented in dwg. 5.;EFFECT: invention provides creating polyepitope vaccine protein which is applicable for immunisation against murrain virus.;5 cl, 7 dwg, 2 tbl, 6 ex
机译:发明领域本发明涉及适用于针对鼠疫病毒的免疫的多表位疫苗蛋白,编码该蛋白的核酸,用于在植物中产生所述蛋白的重组质粒pA7248-AMV-H-PE以及用于预防的疫苗制剂并防止由小病毒引起的感染。多表位疫苗蛋白具有氨基酸序列SEQ ID NO:1,其包含VP4蛋白的B细胞表位的氨基酸序列,从N末端开始的第21至40个氨基酸,B的氨基酸序列从N端开始的135位至160位氨基酸的VP1蛋白的细胞表位,从N端开始的200至213位氨基酸的VP1蛋白的B细胞表位的氨基酸序列,从N端开始,2C蛋白的T细胞表位的氨基酸序列从第68个氨基酸到第76个氨基酸,3D蛋白的T细胞表位的氨基酸序列从第1个氨基酸到第115个氨基酸从N末端开始,以及3D蛋白的T细胞表位的氨基酸序列(从M /台湾/ 99型鼠疫病毒的第421位到第460位氨基酸)。编码这种蛋白的核酸具有核苷酸序列SEQ ID NO:2。重组质粒pA7248-AMV-H-PE具有以dwg表示的物理图。 5,效果:本发明提供了一种多表位疫苗蛋白的制备,适用于针对木兰病毒的免疫接种; 5 cl,7 dwg,2 tbl,6 ex

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号